EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma

Xiang-Ling Wu iD, Bing-Zhi Duan, Zhi-Hua Jiang, Shan-Shan Zeng, Guo-Cheng Lin, Zhong-Liao Fang

Technology in Cancer Research & Treatment · 2026-04 · 25

DOI: 10.1177/15330338261444986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 18.04.2026. Verfasst von Xiang-Ling Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Nomograms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We introduce a standardized necrosis rate—percent reduction in enhancing tumor diameter normalized by baseline tumor diameter—with a threshold of ≥30%. This endpoint is derived from the mRECIST partial response criteria but is normalized to mitigate tumor size-dependent bias. A clinical–radiomics model was developed to assess necrosis in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE).

Methods

Retrospectively, 95 HCC patients undergoing TACE were included. Radiomics features were selected via LASSO regression, and clinical variables via logistic regression. Separate radiomics and clinical models were developed, and a combined model was constructed using multivariable logistic regression. The cohort was randomly split into training (70%) and validation (30%) sets, with all preprocessing, feature selection, and model training confined to the training set to prevent data leakage. Model performance was evaluated using discrimination (AUC), calibration, clinical utility (decision curve analysis), and a nomogram.

Results

From 1,316 extracted radiomics features, six were retained for Rad-score calculation. Key clinical predictors included hepatitis group, standardized viable tumor ratio, and vascular invasion. The integrated model achieved AUCs of 0.865 (95% CI: 0.768–0.961) in training and 0.853 (95% CI: 0.716–0.990) in validation (n=29), outperforming the clinical model (AUCs: 0.808 (95% CI: 0.695-0.922) and 0.666 (95% CI: 0.465-0.866), respectively). Decision curve analysis and calibration plots confirmed the combined model’s superior performance.

Conclusion

The radiomics–clinical nomogram, based on a standardized necrosis rate, may enable early prediction of TACE response, offering potential insights for therapeutic decision-making, risk stratification, and liver transplantation management. External validation is warranted before clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularChemoembolization, TherapeuticNomogramsHumansRadiomicsFemaleNecrosisMaleMiddle AgedAgedTreatment OutcomePrognosisROC CurveTomography, X-Ray Computed

Stichwörter der Autor:innen

hepatocellular carcinoma (HCC)necrosispredictive modelradiomicstransarterial chemoembolization (TACE)

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China.
  • Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control (Guangxi Zhuang Autonomous Region Academy of Preventive Medicine), Nan…
  • Department of Otolaryngology-Head and Neck Surgery, Tongren Second People's Hospital, Tongren, Guizhou, China.
  • Department of Radiology, The Second People's Hospital of China Three Gorges University, Yichang, Hubei, China.

ORCID-Profile: Xiang-Ling Wu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Wu, X. L., Duan, B. Z., Jiang, Z. H., Zeng, S. S., Lin, G. C., & Fang, Z. L. (2026). A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261444986

Vancouver

Wu XL, Duan BZ, Jiang ZH, Zeng SS, Lin GC, Fang ZL. A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261444986

BibTeX
@article{Wu2026,
  author = {Wu, Xiang-Ling and Duan, Bing-Zhi and Jiang, Zhi-Hua and Zeng, Shan-Shan and Lin, Guo-Cheng and Fang, Zhong-Liao},
  title = {A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261444986}
}
Kostenlos starten →